Wide Versus Narrow Excision Margins for High-Risk, Primary Cutaneous Melanomas: Long-Term Follow-Up of Survival in a Randomised Trial

The Lancet Oncology - United Kingdom
doi 10.1016/s1470-2045(15)00482-9